Universal influenza SynCon vaccine (Inovio)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameUniversal influenza SynCon vaccine (Inovio)

Drug Alias NameSynCon H5N1 + H1N1 influenza universal vaccineSeasonal flu vaccine (H5N1 + H1N1)Universal influenza (H5N1 + H1N1) SynCon vaccine,FluprimeMulti-subtype SynCon vaccine targeting H1N1 and H5N1 influenzaINO-3510 +[12]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInovio Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInovio Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A